Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Synovial Fluids of Patients with Temporomandibular Joint Osteoarthritis

Journal of Orofacial Pain

Volumn 14, Issue 1, 2000, Pages 20-30

  Kanyama, Manabu ^a   Kuboki, Takuo ^a   Kojima, Shunji ^a   Fujisawa, Takuo ^a   Hattori, Takako ^a   Takigawa, Masaharu ^a   Yamashita, Atsushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Matrix metalloproteinase; Osteoarthritis; Synovial fluid; Temporomandibular joint; Tissue inhibitor of metalloproteinase

Indexed keywords

DIAGNOSTIC AGENT; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; PROTEIN; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; ADULT; ARTICLE; ARTICULAR CARTILAGE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; STATISTICS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS; PROTEASE INHIBITORS; PROTEINS; STATISTICS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034572272     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. American Academy of Orofacial Pain. Diagnostic Classification. In: McNeill C (ed). Temporomandibular Disorders: Guidelines for Classification, Assessment, and Management. Chicago: Quintessence, 1993:39-60.
2. Hong AJ, Sokoloff L. Pathology of osteoarthritis. In: McCarty DJ (ed). Arthritis and Allied Conditions. Philadelphia: Lea & Febiger, 1989:1571-1594.
3. Nagase H, Woessner JF Jr. Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF Jr, Howell DS (eds). Joint Cartilage Degradation. New York: Marcel Dekker, 1993:159-185.
4. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proreoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-189.
5. Cooksley S, Hipkiss JB, Tickle SP, Holmesievers F, Docherty AJP, Murphy G, Lawson ADG. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix 1990;10:285-291.
6. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K. Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997; 55:20-27.
7. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami K. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-198.
8. Fessier LI, Duncan KG, Fessler JH, Salo T, Tryggvason K. Characterization of procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 1984;259:9783-9789.
9. Haskin CL, Milam SB, Cameron IL. Pathogenesis of degenerative joint disease in the temporomandibular joint. Crit Rev Oral Biol Med 1995;6:248-277.
10. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier J-M, Pelletier J-P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-815.
11. Orsini MG, Kuboki T, Terada S, Matsuka Y, Yamashita A, Clark GT. Diagnostic value of four criteria to interpret temporomandibular joint normal disk position on magnetic resonance images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:489-497.
12. Matsuka Y, Iton S, Minakuchi H, Kuboki T, Yamashita A. Validity of questionnaire for epidemiological studies on symptoms of temporomandibular disorders. J Jpn Soc Temporomandib Joint 1997;9:80-91.
13. Okada Y, Harris EDJ, Nagase H. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophynylmercuric acetate. Biochem J 1988;25:731-741.
14. Kopp S, Wenneberg B, Clemensson E. Clinical microscopical and biochemical investigation of synovial fluid from temporomandibular joint. Scand J Dent Res 1983; 91:33-41.
15. Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg 1991;48:968-971.
16. Sapolsky AI, Altman RD, Woessner JF Jr, Howell DS. The action of cathepsin D in human cartilage on proteoglycans. J Clin Invest 1973;52:624-633.
17. Bayliss MT, Ali Y. Studies on cathepsin B in human articular cartilage. Biochem J 1978;171:149-154.
18. Dingle JT, Knight CG. The role of the chondrocyte microenvironment in the degradation of cartilage matrix. In: Verbruggen G, Veys EM (eds). Degenerative Joints, vol 2. Amsterdam: Excerpta Med, 1985:69-75.
19. Hembry RM, Knight CG, Dingle JT, Barrett AJ. Evidence that extracellular cathepsin D is not responsible for the resorption of cartilage matrix in culture. Biochem Biophys Acta 1982;714:307-312.
20. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-685.
21. Martel-Pelletier J, Pelletier J-P, Cloutier J-M, Howell DS, Ghandur-Mnaymneh L, Woessner JF Jr. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 1984;27:305-312.
22. Martel-Pelletier J, Pelletier J-P, Malemud CJ. Activation of neutral metalloproteinase in human osteoarthritic knee cartilage: Evidence for degradation in the core protein of sulfated proteoglycan. Ann Rheum Dis 1988;47:801-808.
23. Pelletier J-P, Martel-Pelletier J, Malemud CJ. Canine osteoarthritis: Effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycans. J Orthop Res 1988;6:379-388.
24. Carlson DS. Growth of the temporomandibular joint. In: Zarb GA, Carlsson GE, Sessle BJ, Mohl ND (eds). Temporomandibular Joint and Masticatory Muscle Disorders. Copenhagen: Munksgaard, 1994:128-155.
25. Dean DD, Woessner JF Jr. Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases. BiochemJ 1984;218:277-280.
26. Dean DD, Azzo W, Martel-Pelletier J, Pelletier J-P, Woessner JF Jr. Levels of metalloproteinases in human osteoarthritic cartilage. J Rheum 1987;14(suppl):43-44.
27. Clark IM, Powell LK, Samsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36: 372-379.
28. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995;54:25-32.
29. Pelletier J-P, Mineau F, Faure M-P, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33:1466-1476.
30. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-690.
31. Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the intergloblar domain of human aggrecan: Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 1992;267:1008-1014.
32. Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysin. J Biol Chem 1992;266:15579-15582.
33. Hughes C, Murphy G, Hardingham TE. Metalloproteinase digestion of cartilage proteoglycan: Pattern of cleavage by stromelysin and susceptibility to collagenase. Biochem J 1991;279:733-739.
34. Handley CJ, Ilic MZ, Mok MT, Robinson HC. Mechanism of catabolism of the large aggregating proteoglycan by explant cultures of articular cartilage. In; Kuetter K, Schleyerbach R, Peyron J, Hascall VC (eds). Articular Cartilage and Osteoarthritis. New York: Raven Press, 1992.
35. Liu J, Roughley PJ, Mort JS. Identification of human intervertebral disc stromelysin and its involvement in matrix degradation. J Orthop Res 1991;9:568-575.
36. Nguyen Q, Liu J, Roughley PJ, Mort JS. Link protein as a monitor in situ of endogeneous proteolysis in adult human articular cartilage. Biochem 1991;278:143-147.
37. Wu J-J, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen Types II, IX, X, and XI of cartilage. J Biol Chem 1991;266:5625-5628.
38. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochem 1990;29:10261-10270.
39. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Huchinson NI, et al. Expression of 92 kD Type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin-1. J Clin Invest 1993;92:179-185.
40. Seki M, Uzuki M, Ohmoto H, Yoshino K, Maeda S, Kokubun S, et al. Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis. Ryumachi 1995; 35:792-801.
41. Fujisawa T, Hattori T, Takahashi K, Kuboki T, Yamashita A, Takigawa M. Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J Biochem 1999;125(5): 966-975.